Image via WikipediaSimponi Approved for Immune-Related Arthritis
From HealthDay News:
Simponi (golimumab) has been approved by the FDA to treat three forms of arthritis that occur when the body's immune system attacks the joints.
The injected drug will be prescribed to treat moderate-to-severe rheumatoid arthritis, active psoriatic arthritis, and active ankylosing spondylitis.
It arrives on the market with a black box warning in place: Users will face an increased risk of tuberculosis and invasive fungal infections.